New Drug Delivery Systems in Inflammatory Bowel Disease: MMX™ and Tailored Delivery to the Gut

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|17|1851-1857

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.17, 2010-06, pp. : 1851-1857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Delivery of Steroids in Inflammatory Bowel Disease

By  

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 345-349

Bentham Science Publishers

Access to resources Recommend Favorite

The Gut Microbiota in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1528-1536

Bentham Science Publishers

Access to resources Recommend Favorite

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease

By Mitsuyama Keiichi   Sata Michio  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite

The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems

By  

Current Pharmaceutical Biotechnology, Vol. 6, Iss. 1, 2005-02 ,pp. : 3-5

Bentham Science Publishers

Access to resources Recommend Favorite

New Drug Delivery Systems Based on Chitosan

By  

Current Drug Discovery Technologies, Vol. 5, Iss. 4, 2008-12 ,pp. : 333-341

Bentham Science Publishers

Access to resources Recommend Favorite